Wenbin Liu
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 9
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 21
- RNA modifications and cancer 19
- Cancer-related gene regulation 18
- Ubiquitin and proteasome pathways 12
- PI3K/AKT/mTOR signaling in cancer 7
- Biological Psychiatry top 5%
-
- Effects and risks of endocrine disrupting chemicals 11
- Physiology top 5%
-
- Cancer-related Molecular Pathways 13
- Journals
- SHILAP Revista de lepidopterología (1 paper)Environmental Science & Technology (2 papers)Blood (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wenbin Liu
137 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 740
- Molecular Biology 2.9k
- Biological Psychiatry 105
- Health, Toxicology and Mutagenesis 450
- Physiology 711
Countries citing papers authored by Wenbin Liu
This map shows the geographic impact of Wenbin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Liu more than expected).
Fields of papers citing papers by Wenbin Liu
This network shows the impact of papers produced by Wenbin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Liu. The network helps show where Wenbin Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenbin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 25 | |
| 10 | 2022 | 14 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 3 | |
| 15 | 2020 | 92 | |
| 16 | 2019 | 24 | |
| 17 | 2018 | 57 | |
| 18 | 2018 | 26 | |
| 19 | 2018 | 12 | |
| 20 | 2018 | 35 |
About Wenbin Liu
Wenbin Liu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 148 papers that have together received 4.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (21 papers), RNA modifications and cancer (19 papers), Cancer-related gene regulation (18 papers), Cancer-related Molecular Pathways (13 papers), Ubiquitin and proteasome pathways (12 papers), Effects and risks of endocrine disrupting chemicals (11 papers), Cancer-related molecular mechanisms research (9 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Cancer Research (740 citations), Molecular Biology (2.9k citations) and Biological Psychiatry (105 citations). Wenbin Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jia Cao, Jinyi Liu, Jingchuan Xue, Kurunthachalam Kannan, Feng Gao, Fei Han, Xiaoyan Liu, Xinchun Yang, Jing Li and Bin Geng. Their work appears in journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.